Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Biopharmaceuticals Market Analysis
8.1 Key Industry Highlights
8.2 Global Biopharmaceuticals Historical Market (2019-2025)
8.3 Global Biopharmaceuticals Market Forecast (2026-2035)
8.4 Global Biopharmaceuticals Market by Product Type
8.4.1 Monoclonal Antibodies
8.4.1.1 Historical Trend (2019-2025)
8.4.1.2 Forecast Trend (2026-2035)
8.4.1.3 Breakup by Type
8.4.1.3.1 Anti-Cancer Monoclonal Antibodies
8.4.1.3.2 Anti-Inflammatory Monoclonal Antibodies
8.4.1.3.3 Others
8.4.2 Recombinant Growth Factors
8.4.2.1 Historical Trend (2019-2025)
8.4.2.2 Forecast Trend (2026-2035)
8.4.2.3 Breakup by Type
8.4.2.3.1 Erythropoietin
8.4.2.3.2 Granulocyte Colony Stimulating Factor
8.4.3 Purifed Proteins
8.4.3.1 Historical Trend (2019-2025)
8.4.3.2 Forecast Trend (2026-2035)
8.4.3.3 Breakup by Type
8.4.3.3.1 Leukemia Inhibitory Factor (LIF)
8.4.3.3.2 P53 Protein
8.4.3.3.3 P38 Protein
8.4.3.3.4 Others
8.4.4 Recombinant Proteins
8.4.4.1 Historical Trend (2019-2025)
8.4.4.2 Forecast Trend (2026-2035)
8.4.4.3 Breakup by Type
8.4.4.3.1 Serum Albumin
8.4.4.3.2 Amyloid Protein
8.4.4.3.3 Defensin
8.4.4.3.4 Transferrin
8.4.5 Recombinant Hormones
8.4.5.1 Historical Trend (2019-2025)
8.4.5.2 Forecast Trend (2026-2035)
8.4.5.3 Breakup by Type
8.4.5.3.1 Recombinant Human Growth Hormones
8.4.5.3.2 Recombinant Insulin
8.4.5.3.3 Others
8.4.6 Vaccines
8.4.6.1 Historical Trend (2019-2025)
8.4.6.2 Forecast Trend (2026-2035)
8.4.6.3 Breakup by Type
8.4.6.3.1 Recombinant Vaccines
8.4.6.3.2 Breakup by Type
8.4.6.3.2.1 Cancer Vaccines
8.4.6.3.2.2 Malaria Vaccines
8.4.6.3.2.3 Ebola Vaccine
8.4.6.3.2.4 Hepatitis B Vaccine
8.4.6.3.2.5 Tetanus Vaccine
8.4.6.3.2.6 Diphtheria Vaccine
8.4.6.3.2.7 Cholera Vaccines
8.4.6.3.2.8 Others
8.4.6.3.3 Conventional Vaccines
8.4.6.3.4 Breakup by Type
8.4.6.3.4.1 Polio Vaccine
8.4.6.3.4.2 Pox Vaccine
8.4.6.3.4.3 Others
8.4.7 Recombinant Enzymes
8.4.7.1 Historical Trend (2019-2025)
8.4.7.2 Forecast Trend (2026-2035)
8.4.7.3 Breakup by Type
8.4.7.3.1 Enterokinase
8.4.7.3.2 Cyclase
8.4.7.3.3 Caspase
8.4.7.3.4 Cathepsin
8.4.8 Cell and Gene Therapies
8.4.8.1 Historical Trend (2019-2025)
8.4.8.2 Forecast Trend (2026-2035)
8.4.8.3 Breakup by Type
8.4.8.3.1 Allogenic Products
8.4.8.3.2 Autologous Products
8.4.8.3.3 Acellular Products
8.4.9 Synthetic Immunomodulators
8.4.9.1 Historical Trend (2019-2025)
8.4.9.2 Forecast Trend (2026-2035)
8.4.9.3 Breakup by Type
8.4.9.3.1 Cytokines, Interferons, and Interleukins
8.4.10 Others
8.5 Global Biopharmaceuticals Market by Therapeutic Application
8.5.1 Oncology
8.5.1.1 Historical Trend (2019-2025)
8.5.1.2 Forecast Trend (2026-2035)
8.5.2 Inflammatory and Infectious Diseases
8.5.2.1 Historical Trend (2019-2025)
8.5.2.2 Forecast Trend (2026-2035)
8.5.3 Autoimmune Disorders
8.5.3.1 Historical Trend (2019-2025)
8.5.3.2 Forecast Trend (2026-2035)
8.5.4 Metabolic Disorders
8.5.4.1 Historical Trend (2019-2025)
8.5.4.2 Forecast Trend (2026-2035)
8.5.5 Hormonal Disorders
8.5.5.1 Historical Trend (2019-2025)
8.5.5.2 Forecast Trend (2026-2035)
8.5.6 Cardiovascular Diseases
8.5.6.1 Historical Trend (2019-2025)
8.5.6.2 Forecast Trend (2026-2035)
8.5.7 Neurological Diseases
8.5.7.1 Historical Trend (2019-2025)
8.5.7.2 Forecast Trend (2026-2035)
8.5.8 Others
8.6 Global Biopharmaceuticals Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2019-2025)
8.6.1.2 Forecast Trend (2026-2035)
8.6.2 Europe
8.6.2.1 Historical Trend (2019-2025)
8.6.2.2 Forecast Trend (2026-2035)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2019-2025)
8.6.3.2 Forecast Trend (2026-2035)
8.6.4 Latin America
8.6.4.1 Historical Trend (2019-2025)
8.6.4.2 Forecast Trend (2026-2035)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2019-2025)
8.6.5.2 Forecast Trend (2026-2035)
9 North America Biopharmaceuticals Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2019-2025)
9.1.2 Forecast Trend (2026-2035)
9.2 Canada
9.2.1 Historical Trend (2019-2025)
9.2.2 Forecast Trend (2026-2035)
10 Europe Biopharmaceuticals Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2019-2025)
10.1.2 Forecast Trend (2026-2035)
10.2 Germany
10.2.1 Historical Trend (2019-2025)
10.2.2 Forecast Trend (2026-2035)
10.3 France
10.3.1 Historical Trend (2019-2025)
10.3.2 Forecast Trend (2026-2035)
10.4 Italy
10.4.1 Historical Trend (2019-2025)
10.4.2 Forecast Trend (2026-2035)
10.5 Others
11 Asia Pacific Biopharmaceuticals Market Analysis
11.1 China
11.1.1 Historical Trend (2019-2025)
11.1.2 Forecast Trend (2026-2035)
11.2 Japan
11.2.1 Historical Trend (2019-2025)
11.2.2 Forecast Trend (2026-2035)
11.3 India
11.3.1 Historical Trend (2019-2025)
11.3.2 Forecast Trend (2026-2035)
11.4 ASEAN
11.4.1 Historical Trend (2019-2025)
11.4.2 Forecast Trend (2026-2035)
11.5 Australia
11.5.1 Historical Trend (2019-2025)
11.5.2 Forecast Trend (2026-2035)
11.6 Others
12 Latin America Biopharmaceuticals Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2019-2025)
12.1.2 Forecast Trend (2026-2035)
12.2 Argentina
12.2.1 Historical Trend (2019-2025)
12.2.2 Forecast Trend (2026-2035)
12.3 Mexico
12.3.1 Historical Trend (2019-2025)
12.3.2 Forecast Trend (2026-2035)
12.4 Others
13 Middle East and Africa Biopharmaceuticals Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2019-2025)
13.1.2 Forecast Trend (2026-2035)
13.2 United Arab Emirates
13.2.1 Historical Trend (2019-2025)
13.2.2 Forecast Trend (2026-2035)
13.3 Nigeria
13.3.1 Historical Trend (2019-2025)
13.3.2 Forecast Trend (2026-2035)
13.4 South Africa
13.4.1 Historical Trend (2019-2025)
13.4.2 Forecast Trend (2026-2035)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Amgen Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 AbbVie Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Bristol-Myers Squibb Company.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Eli Lilly and Company
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Novo Nordisk A/S
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Pfizer Inc.
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 GlaxoSmithKline plc.
16.2.7.1 Company Overview
16.2.7.2 Product Portfolio
16.2.7.3 Demographic Reach and Achievements
16.2.7.4 Certifications
16.2.8 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Biopharmaceuticals Market: Key Industry Highlights, 2019 and 2035
2. Global Biopharmaceuticals Historical Market: Breakup by Product Type (USD Billion), 2019-2025
3. Global Biopharmaceuticals Market Forecast: Breakup by Product Type (USD Billion), 2026-2035
4. Global Biopharmaceuticals Historical Market: Breakup by Therapeutic Application (USD Billion), 2019-2025
5. Global Biopharmaceuticals Market Forecast: Breakup by Therapeutic Application (USD Billion), 2026-2035
6. Global Biopharmaceuticals Historical Market: Breakup by Region (USD Billion), 2019-2025
7. Global Biopharmaceuticals Market Forecast: Breakup by Region (USD Billion), 2026-2035
8. North America Biopharmaceuticals Historical Market: Breakup by Country (USD Billion), 2019-2025
9. North America Biopharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2026-2035
10. Europe Biopharmaceuticals Historical Market: Breakup by Country (USD Billion), 2019-2025
11. Europe Biopharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2026-2035
12. Asia Pacific Biopharmaceuticals Historical Market: Breakup by Country (USD Billion), 2019-2025
13. Asia Pacific Biopharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2026-2035
14. Latin America Biopharmaceuticals Historical Market: Breakup by Country (USD Billion), 2019-2025
15. Latin America Biopharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2026-2035
16. Middle East and Africa Biopharmaceuticals Historical Market: Breakup by Country (USD Billion), 2019-2025
17. Middle East and Africa Biopharmaceuticals Market Forecast: Breakup by Country (USD Billion), 2026-2035
18. Global Biopharmaceuticals Market Structure
*The list of players in the competitive landscape section can be customised or made more exhaustive based on your specific requirements.*